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Ocular Pathology of Fukuyama
Congenital Muscular Dystrophy
Tomoko Yamamoto, Yoichiro Kato and Noriyuki Shibata
Abstract
Fukuyama congenital muscular dystrophy (FCMD) is one of the congenital
muscular dystrophies, showing central nervous system (CNS) and ocular lesions, in
addition to muscular dystrophy. It is included in α-dystroglycanopathy, an entity of
muscular dystrophies caused by reduced glycosylation of α-dystroglycan (α-DG).
Studies of ocular lesions are not so many, compared with those of the muscle and
CNS. Clinical ocular manifestations are myopia, strabismus, retinal detachment,
and so on. Since the retina has a structure partly resembling the cerebral cortex,
pathological findings similar to those found in the brain have been reported. The
major observation considered to be involved in the pathogenesis of retinal lesions is
abnormalities in the internal limiting membrane formed by Müller cells, which is
corresponding to the glia limitans formed by astrocytes in the brain. Fukutin,
responsible for FCMD, and α-DG are expressed in Müller cells. Moreover, fukutin
may be involved in synaptic functions of retinal neurons through the glycosylation
of α-DG. In this chapter, ocular lesions of fetal and child FCMD patients are
presented, especially focusing on pathological findings of the retina, and functions
of fukutin are discussed.
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1. Introduction
Fukuyama congenital muscular dystrophy (FCMD), described by Fukuyama
et al., is an autosomal recessive disease, exclusively found in Japan [1, 2]. In addition
to the muscular dystrophy, central nervous system (CNS) and eye anomalies are
accompanied. Although there are mild to severe cases, patients are generally noticed
as floppy infant, exhibit progressive muscular dystrophy and mental retardation,
and die before 30 years [2]. The responsible gene is fukutin on chromosome 9q31
[3]. Among congenital muscular dystrophies, Walker Warburg syndrome (WWS)
and muscle-eye-brain disease (MEB) show characteristics similar to FCMD [4, 5],
although patients of FCMD show milder symptoms compared to those of WWS and
MEB, in general [6]. Since responsible genes for WWS, MEB, and FCMD are
implicated in the glycosylation of α-dystroglycan (α-DG), they are included in the
entity of α-dystroglycanopathy [6].
At the sarcolemma of skeletal muscle, there is a complex composed of
several proteins, including dystroglycans, sarcoglycans, and dystrophin. It is called
the dystrophin-glycoprotein complex (DGC) that links extracellular matrix and
intracellular proteins. The DGC is also observed in the CNS and in the eye.
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The glycosylated area of α-DG existed outside the cell membrane works as a recep-
tor for extracellular matrix proteins like laminin [6–8]. Thus, the glycosylation of
α-DG is indispensable for formation of the basement membrane. To accomplish a
fully glycosylated α-DG, several proteins, such as protein-O-mannosyltransferase
1/2 (POMT1/2) [9–11], O-linked mannose 1,2-N-acetylglucosaminyltransferase
(POMGnT1) [12], fukutin [13], fukutin-related protein (FKRP) [14], and LARGE
[15], are required. The recent study proves that fukutin transfers ribitol 5-phos-
phate to sugar chains of α-DG, which is necessary to make a functional α-DG [13].
Muscular dystrophies showing reduced glycosylation of α-DG due to malfunc-
tion of above proteins that add sugars on the glycosylation domain of α-DG are
categorized to α-dystroglycanopathy, which include severe diseases like WWS,
MEB, and FCMD to rather milder diseases like congenital muscular dystrophy 1C
(MDC1C) [16], MDC1D [17], limb-girdle muscular dystrophy 2I (LGMD 2I) [16]
LGMD2K, and LGMD2M [18]. In severe ones, CNS and eye anomalies are obvious.
The CNS anomaly is represented by cortical dysplasia, generally called cobblestone
lissencephaly [6, 7]. In FCMD, the cerebrum and cerebellum generally show an
appearance of polymicrogyri [19–21]. In the surface of CNS, astrocytic endfeet form
the glia limitans covered with the basement membrane, and both fukutin and α-DG
are expressed in astrocytes [7, 22]. In the fetal FCMD brain, irregular disruptions of
the glia limitans are observed. Neuronal tissues overmigrate from defects of glia
limitans (Figure 1), which is considered to be the main cause of cobblestone
lissencephaly [7, 8]. Hypoglycosylation of α-DG by malfunction of fukutin makes
Figure 1.
Cerebral lesions of a FCMD fetus. The cerebral hemisphere almost retains fundamental structure (A). The glia
limitans of the cerebral surface is irregularly disrupted, and neuronal tissues overmigrate through the
disruptions (B, C; arrows). (B) Periodic acid-methenamine-silver (PAM) staining. (C) Photoshop-aided
double immunostaining [25] of nestin (green) and synaptophysin (brown). BG: basal ganglia, GM: germinal
matrix,T: thalamus.
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the basement membrane fragile and this gives rise to partial defects in the glia
limitans. Amounts of overmigrated neuronal tissues are various, depending on the
size of defects [20, 23, 24].
Compared with the muscular and CNS lesions, studies about the ocular anomaly
are rather scarce, but intriguing observations have been reported. Among the com-
ponents of the eye, the retina has some characteristics common to the cerebral
cortex. In this chapter, ocular lesions of FCMD are described, mainly focusing on
retinal dysplasia and introducing resent studies on pathogenesis.
2. Normal development and structure of the eye
2.1 Normal development of the eye
Many genes are involved in the formation of ocular structure [26]. Morpholog-
ically, the initial eye structure becomes observable after 3 weeks of the gestation, as
a pair of optic sulci at the rostral neural plate. By 4 weeks, the optic sulcus grows to
form the optic vesicle, the proximal part of which develops to be the optic stalk, the
future optic nerve, and the rest of which to be the optic cap. The distal part of the
optic vesicle is closely adjacent to the surface ectoderm that develops to the lens
after forming the lens vesicle by invagination. The lens vesicle is separated from the
surface ectoderm at 6 and half weeks. The corneal epithelium begins to be formed
from the surface ectoderm by 7 weeks. The choroid and the sclera develop from the
periocular mesenchyme by 15 weeks.
The retina is differentiated from the optic cap. The inner layer of the optic cap
becomes the neural retina, and the outer layer becomes the retinal pigmented
epithelium. After retinal neurons are born, they move to their proper place, mim-
icking the development of CNS. However, the retina has its own mode for lamina-
tion [27]. In the retina, retinal ganglion cells and cone photoreceptors differentiate
earlier, and then rod photoreceptors, bipolar cells, and Müller cells [26–28].
2.2 Normal structure of the eye
The eyeball can be divided into the anterior and posterior segments. The anterior
segment includes the cornea, anterior and posterior chambers, iris, and lens. The poste-
rior segment contains the vitreous, retina, choroid, sclera, and optic nerve (Figure 2).
Histologically, the normal retina consists of the inner and outer segments of
photoreceptors, outer nuclear layer, outer plexiform layer, inner nuclear layer,
inner plexiform layer, ganglion cell layer, and nerve fiber layer (Figure 2). Outer
segments of the photoreceptor are loosely connected to retinal pigmented epithelia.
Microvilli of the pigmented epithelium surround the outer segments of photore-
ceptors [29]. The outer nuclear layer contains nuclei of the photoreceptors, the rod
and cone. Rods are extremely sensitive to light, while cones are involved in the color
vision. In the outer plexiform layer, photoreceptors form synapses between bipolar
cells: roughly, rods to rod bipolar cells and cones to cone bipolar cells. Rod bipolar
cells depolarize (ON) to the increase of light intensity. On the other hand, cone
bipolar cells either ON or hyperpolarize (OFF) [28]. The inner nuclear layer is
mainly formed by bipolar cells. Cell bodies of amacrine cells, horizontal cells, and
Müller cells are also contained. In the inner plexiform layer, synapses are formed
between retinal ganglion cells and bipolar cells or amacrine cells. Synapses with ON-
bipolar cells are seen in the inner lamina of the inner plexiform layer and those with
OFF-bipolar cells in the outer lamina [28]. In the ganglion cell layer, single to
several layers of retinal ganglion cells are observed. The nerve fiber layer consisted
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of nerve fibers of retinal ganglion cells is situated beneath the inner limiting mem-
brane that is formed at the inner surface of the retina by Müller cells. The external
limiting membrane is formed by zonula adherens between Müller cells and inner
segments of photoreceptor [29]. The basement membrane is abutted above the
inner limiting membrane and beneath the basal surface of pigmented epithelium,
attaching to the Bruch’s membrane [29]. The basement membrane is also formed
around capillaries.
3. Ocular lesions of FCMD
3.1 Clinical observations
In FCMD, both anterior and posterior components of the eye can be affected.
Clinical symptoms include myopia, strabismus, and nystagmus [30–32]. Cataract,
Figure 2.
(A) Schema of normal eye structure and (B) structure of normal retina.
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atrophy of the optic nerve, and retinal detachment are also known. Severe cases
may show microphthalmia [31]. Electroretinogram (ERG) of FCMD patients may
be normal, but abnormal findings may be seen in both dark-adapted and light-
adapted ERGs [32]. Patients of WWS and MEB, severe forms of α-dystrogly-
canopathy, also exhibit abnormalities in anterior and posterior components. In
WWS, varieties of lesions are described, such as cataract, microcornea,
microphthalmia, retinal detachment, retinal dysplasia, and optic atrophy [4]. Glau-
coma and buphthalmos also may be observed. Clinical ocular findings of MEB
reported are myopia, nystagmus, optic atrophy, and retinal degeneration [33]. ERG
is abnormal as well. Like the CNS, ocular anomalies of FCMD are less severe than
those of WWS and MEB [30, 31].
3.2 Histological findings
Although histological examinations of the eye of fetal FCMD cases are not so
many, findings similar to those of the cerebrum can be found [31]. The inner
limiting membrane is irregularly disrupted and ganglion cells exist beyond the inner
limiting membrane, while there are areas exhibiting no apparent light microscopical
abnormalities (Figure 3). Like child cases, some fetal cases may show local folding
and fusion of the retina [31].
In child FCMD cases, detachment, local folding, and fusion of the retina are
observed (Figure 4). The inner limiting membrane is discontinuous. A persistent
Figure 3.
Retinal findings in FCMD fetus. The internal limiting membrane, clearly depicted by PAM staining, is discontinuous
in some part (A, B; arrows), while there are areas showing normal retinal appearance with continuous internal
limiting membrane (C, D). Ectopic ganglion cells are observed beyond the inner limiting membrane.
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hyperplastic primary vitreous body and a persistent hyaloid artery are also reported
[31]. In severe cases, the layer of retina is markedly distorted with or without
rosette formation. The outer and inner nuclear layers became thin in part. The layer
of photoreceptor is also deranged with abnormal appearances of periodic acid-
methenamine-silver (PAM)-positive structure (Figure 4). Reactive gliosis can be
seen [31]. Severity of retinal dysplasia appears to be parallel to that of the CNS
lesion [31].
3.3 Pathological consideration on retinal lesions of FCMD
In the CNS, fukutin and other related proteins are expressed in both glial cells
and neurons [7, 34, 35]. Similarly, in the eye, fukutin is expressed in retinal neurons
in addition to Müller cells [31, 36] (Figure 5).
Just above the inner limiting membrane formed by Müller cells abutted the
basement membrane containing components of the DGC [37–39]. Like the CNS,
abnormal basement membrane in the retinal surface may be involved in the patho-
genesis of retinal dysplasia [31]. Focal fusion of the retina also may be caused by
abnormal basement membrane. The glycosylation of α-DG is decreased in the inner
limiting membrane of FCMD cases. Abnormalities of the basement membrane [40],
decreased glycosylation of α-DG at the inner limiting membrane, and reactive
gliosis [41] also have been reported in model mice of MEB. The study using α-
dystroglycanopathy model mice and dystroglycan mutant mice suggest that DG is
required for the maturation and maintenance of the inner limiting membrane,
rather than its initial formation [42]. Retinal neurons can migrate properly under
well-formed inner limiting membrane [42]. Although fukutin-null mice are lethal
during pregnancy [43], the basic structure of retina and brain is relatively well kept
in the early stage of the gestation of FCMD patients. Fukutin is considered to be
essential for the embryogenesis. Severity of anomalies depends on a degree of
functional loss of fukutin. On the brain of FCMD, lesions appear to be obvious after
the second trimester. Strength of the surface structure may not catch up with the
rapid increase of the volume of eye and brain. One of the interesting things is that
the glycosylation of α-DG around the capillary is maintained. In POMGnT1 knock-
out mice, the basement membrane of pigmented epithelium looks intact [40].
Müller cells have various roles to maintain retinal functions. One of the roles
is to eliminate an excess of glutamate, a major transmitter in the retina, from the
synaptic space. Glutamate is transported into Müller cells by glutamate transporter-
1 (GLT-1) and metabolized to ornithine by ornithine aminotransferase (OAT) or to
glutamine by glutamine synthase (GS). In FCMD patients, function of Müller
cells seems to be decreased, because the expression of GLT-1, OAT, and GS is
decreased [31].
In addition to the inner limiting membrane, the dystrophin-glycoprotein com-
plex exists at presynaptic terminals of photoreceptor cells [41, 44]. As a ligand of α-
DG, pikachurin is important for synaptic function between photoreceptor cells and
bipolar cells [44]. In DG-knockout mice, pikachurin is markedly lost in both rod
and cone photoreceptors with the loss of DG in these cells [44]. With the absence of
DG, the retina becomes thin showing a decrease of photoreceptor cells, horizontal
cells, and retinal ganglion cells in mice [42]. Decrease of ERG b-waves is observed
in pikachurin-deficient mice and in dystroglycan-deficient mice [39]. Similar reti-
nal lesions and abnormal ERGs are found in fukutin- [45], POMGnT1- [41], and
Pomt1- [46] deficient mice, and Largemyd and Largevls mice [47]. Hypoglycosylation
of α-DG by hypofunction of fukutin and other proteins is considered to affect the
function of retinal neurons as well as that of Müller cells.
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Figure 4.
Retinal findings in FCMD children. The retina is detached from the pigmented layer and abnormally folded
(A, B), with focal surface fusion (arrows). In a severe case, retinal structure is abnormal with discontinuous
PAM-positive structures, probably in the layer of photoreceptor cells. Normally, there is no such structure in this
layer (C, D). Rosette structures are focally seen (E). The retina becomes thin with scarce retinal neurons (F).
G and H show normal retina. The space indicated by the asterisk is an artifact during tissue preparation. Ch:
choroid, Sc: sclera, GCL: ganglion cell layer, IPL: inner plexiform layer, INL: inner nuclear layer, OPL: outer
plexiform layer, ONL: outer nuclear layer.
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Immunoreaction against antifukutin antibody is found in all the retinal layers,
with stronger intensity in the inner segments of photoreceptors and in the outer
plexiform layer [36]. In our immunostaining on formalin-fixed, paraffin-embedded
human retina, all the layers are stained, but more intense in the outer and inner
nuclear layer (Figure 5). This may due to the difference of tissue preparation like
fixation. As for subcellular localization of fukutin, in retinal cells, it is mainly
localized in the endoplasmic reticulum rather than the Golgi apparatus and in the
nucleus in vivo [36]. Similar localization is observed in carcinoma cell lines [48].
These observations are contradict to the general consideration that fukutin is local-
ized in the Golgi apparatus on cultured cells transfected with fukutin [3]. Further
examinations are needed to explain the difference and clarify the localization of
fukutin in vivo. If fukutin is truly localized in the endoplasmic reticulum and
nucleus, this might suggest further unknown functions of fukutin, regardless of the
relation to the glycosylation of α-DG.
4. Conclusions
Among severe forms of α-dystroglycanopathy like WWS, MEB, and FCMD,
apparent CNS and ocular lesions are accompanied. Pathology of ocular lesions
shares some characteristics common with that of CNS lesions. In this chapter,
representative pathological findings of the eye of FCMD are presented, mainly
focusing on the retinal dysplasia, and its pathogenesis is discussed with the review
of literatures.
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Figure 5.
Expression of fukutin in normal human retina. Fukutin is expressed in both retinal neurons and Müller cells
(A–C). On fluorescent immunohistochemistry (A), fukutin is visualized in red (DAPI: blue). On Photoshop-
aided double immunohistochemistry, green color indicates the elements positive for both fukutin and GFAP.
IPL: inner plexiform layer, INL: inner nuclear layer, OPL: outer plexiform layer, ONL: outer nuclear layer.
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